DECRISTOFORO, C.
73  Ergebnisse:
Personensuche X
?
 
?
2

A proof of concept study with FSC-based hybrid imaging agen..:

Summer, D. ; Mayr, S. ; Petrik, M....
Nuclear Medicine and Biology.  72-73 (2019)  - p. S33-S34 , 2019
 
?
 
?
4

68Ga labelled bacterial siderophore for infection imaging: ..:

Zhai, C. ; Petrik, M. ; Ahmadi, M....
Nuclear Medicine and Biology.  72-73 (2019)  - p. S62 , 2019
 
?
5

68Ga-labelled, fluorescent siderophores: dual imaging poten..:

Kochinke, L. ; Kaeopookum, P. ; Orasch, T....
Nuclear Medicine and Biology.  72-73 (2019)  - p. S62-S63 , 2019
 
?
6

Heterobivalent bioconjugates based on the FSC-scaffold targ..:

Kaeopookum, P. ; Summer, D. ; Ross, T....
Nuclear Medicine and Biology.  72-73 (2019)  - p. S37-S38 , 2019
 
?
7

Molecular Imaging: In Vivo Agents for the Diagnosis and Tre..:

Haeusler, D. ; Decristoforo, C. ; Frost, J...
Contrast Media & Molecular Imaging.  2018 (2018)  - p. 1-2 , 2018
 
?
 
?
 
?
10

Radiopharmaceuticals are special, but is this recognized? T..:

Decristoforo, C. ; Penuelas, I. ; Elsinga, P....
European Journal of Nuclear Medicine and Molecular Imaging.  41 (2014)  11 - p. 2005-2007 , 2014
 
?
11

68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy t..:

Kroiss, A. ; Putzer, D. ; Decristoforo, C....
European Journal of Nuclear Medicine and Molecular Imaging.  40 (2013)  4 - p. 514-523 , 2013
 
?
12

Full automation of 68Ga labelling of DOTA-peptides includin..:

Ocak, M. ; Antretter, M. ; Knopp, R....
Applied Radiation and Isotopes.  68 (2010)  2 - p. 297-302 , 2010
 
?
 
?
14

The specific case of radiopharmaceuticals and GMP—activitie..:

Decristoforo, C. ; Elsinga, P. ; Faivre-Chauvet, A....
European Journal of Nuclear Medicine and Molecular Imaging.  35 (2008)  7 - p. 1400-1401 , 2008
 
?
15

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake..:

von Guggenberg, E. ; Dietrich, H. ; Skvortsova, I....
European Journal of Nuclear Medicine and Molecular Imaging.  34 (2007)  8 - p. 1209-1218 , 2007
 
1-15